
E135: IL17 and a GLP1?
Apr 30, 2026 - 11:03
Radio and PodcastLive Radio & Podcasts
Great trial this week looking at brepocitinib in dermatomyositis. Looks like a winner, expect it will be approved. Where it fits in our approach to IIM is an open question, but nice to have another option. Study: JC Comp...
E134: Brepocitinib in Dermatomyositis (VALOR) is an episode from The Evidence Based Rheumatology Podcast by Michael Putman. Great trial this week looking at brepocitinib in dermatomyositis. Looks like a winner, expect it will be approved. W...
This episode belongs to The Evidence Based Rheumatology Podcast.
Use the player on this page to stream the episode online.
Published Apr 17, 2026, 14:58 long, audio available.
Great trial this week looking at brepocitinib in dermatomyositis. Looks like a winner, expect it will be approved. Where it fits in our approach to IIM is an open question, but nice to have another option. Study: JC Companion:
You can listen to E134: Brepocitinib in Dermatomyositis (VALOR) online on Radio and Podcast. Open the player on this page to stream the available audio.
E134: Brepocitinib in Dermatomyositis (VALOR) is an episode from The Evidence Based Rheumatology Podcast by Michael Putman.
This episode is 14:58 long.
This episode was published on Apr 17, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from The Evidence Based Rheumatology Podcast when more episodes are available from the podcast feed.
You can listen to E134: Brepocitinib in Dermatomyositis (VALOR) on this page when the episode audio is available from the podcast feed.
E134: Brepocitinib in Dermatomyositis (VALOR) is from The Evidence Based Rheumatology Podcast by Michael Putman.
Published Apr 17, 2026 and 14:58 long